Skip to main content
Erschienen in: Herz 5/2014

01.08.2014 | e-Herz: Original article

Framingham risk score and severity of coronary artery disease

verfasst von: M.R. Sayin, MD, M.A. Cetiner, T. Karabag, I. Akpinar, E. Sayin, M.A. Kurcer, S.M. Dogan, M. Aydin

Erschienen in: Herz | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide. Easy-to-perform and reliable parameters are needed to predict the presence and severity of CAD and to implement efficient diagnostic and therapeutic modalities. We aimed to examine whether the Framingham risk scoring system can be used for this purpose.

Methods

A total of 222 patients (96 women, 126 men; mean age, 59.1 ± 11.9 years) who underwent coronary angiography were enrolled in the study. Presence of > %50 stenosis in a coronary artery was assessed as critical CAD. The Framingham risk score (FRS) was calculated for each patient. CAD severity was assessed by the Gensini score. The relationship between the FRS and the Gensini score was analyzed by correlation and regression analyses.

Results

The mean Gensini score was 18.9 ± 25.8, the median Gensini score was 7.5 (0–172), the mean FRS was 7.7 ± 4.2, and the median FRS was 7 (0–21). Correlation analysis revealed a significant relationship between FRS and Gensini score (r = 0.432, p < 0.0001). This relationship was confirmed by linear regression analysis (β = 0.341, p < 0.0001). A cut-off level of 7.5 for FRS predicted severe CAD with a sensitivity of 68 % and a specificity of 73.6 % (ROC area under curve: 0.776, 95 % CI: 0.706–0.845, PPV: 78.1 %, NPV: 62.3 %, p < 0.0001).

Conclusion

Our work suggests that the FRS system is a simple and feasible method that can be used for prediction of CAD severity. As the sample size was small in our study, further large-scale studies are needed on this subject to draw solid conclusions.
Literatur
1.
Zurück zum Zitat Murray CJ, Lopez AD (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349:1269–1276PubMedCrossRef Murray CJ, Lopez AD (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349:1269–1276PubMedCrossRef
2.
Zurück zum Zitat Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349:1436–1442PubMedCrossRef Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349:1436–1442PubMedCrossRef
3.
Zurück zum Zitat Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology. Eur Heart J 27:1341–1381PubMedCrossRef Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology. Eur Heart J 27:1341–1381PubMedCrossRef
4.
Zurück zum Zitat Graham I, Atar D, Borch-Johnsen K et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary: fourth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 28:2375–2414PubMedCrossRef Graham I, Atar D, Borch-Johnsen K et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary: fourth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 28:2375–2414PubMedCrossRef
5.
Zurück zum Zitat Wilson PW, D’Agostino RB, Levy D et al (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847PubMedCrossRef Wilson PW, D’Agostino RB, Levy D et al (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847PubMedCrossRef
6.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
7.
Zurück zum Zitat Judkins MP (1967) Selective coronary arteriography: I: a percutaneous transfemoral technique. Radiology 89:815–824PubMedCrossRef Judkins MP (1967) Selective coronary arteriography: I: a percutaneous transfemoral technique. Radiology 89:815–824PubMedCrossRef
8.
Zurück zum Zitat Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606PubMedCrossRef Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606PubMedCrossRef
9.
Zurück zum Zitat Ford ES, Giles WH, Mokdad AH (2004) The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol 43:1791–1796PubMedCrossRef Ford ES, Giles WH, Mokdad AH (2004) The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol 43:1791–1796PubMedCrossRef
10.
Zurück zum Zitat Eberly LE, Neaton JD, Thomas AJ, Yu D (2004) Multiple Risk Factor Intervention Trial Research Group. Multiple-stage screening and mortality in the multiple risk factor intervention trial. Clin Trials 1:148–161PubMedCrossRef Eberly LE, Neaton JD, Thomas AJ, Yu D (2004) Multiple Risk Factor Intervention Trial Research Group. Multiple-stage screening and mortality in the multiple risk factor intervention trial. Clin Trials 1:148–161PubMedCrossRef
11.
Zurück zum Zitat D’Agostino RB Sr, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 117:743–753CrossRef D’Agostino RB Sr, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 117:743–753CrossRef
12.
Zurück zum Zitat British Cardiac Society, British Hypertension Society, Diabetes UK et al (2005) JBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. Heart 91:v1–v52CrossRef British Cardiac Society, British Hypertension Society, Diabetes UK et al (2005) JBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. Heart 91:v1–v52CrossRef
13.
Zurück zum Zitat Hippisley-Cox J, Coupland C, Vinogradova Y et al (2007) Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 335:136PubMedCentralPubMedCrossRef Hippisley-Cox J, Coupland C, Vinogradova Y et al (2007) Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 335:136PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat National Heart, Lung, and Blood Institute. Framingham Heart Study. Available from: http://www.framinghamheartstudy.org/ National Heart, Lung, and Blood Institute. Framingham Heart Study. Available from: http://​www.​framinghamhearts​tudy.​org/​
15.
Zurück zum Zitat Gulec S (2009) Global risk and objectives in cardiovascular diseases. Turk Kardiyol Dern Ars 37(Suppl 2):1–10 (Article in Turkish)PubMed Gulec S (2009) Global risk and objectives in cardiovascular diseases. Turk Kardiyol Dern Ars 37(Suppl 2):1–10 (Article in Turkish)PubMed
16.
Zurück zum Zitat D’Agostino RB Sr, Grundy S, Sullivan LM et al (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286:180–187CrossRef D’Agostino RB Sr, Grundy S, Sullivan LM et al (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286:180–187CrossRef
17.
Zurück zum Zitat Menotti A, Puddu PE, Lanti M (2000) Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 21:365–370PubMedCrossRef Menotti A, Puddu PE, Lanti M (2000) Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 21:365–370PubMedCrossRef
18.
Zurück zum Zitat Zhang X, Jiang H, Lai J (1998) Relationship between the risk factors of coronary artery disease and the severity of coronary artery lesions. Zhonghua Yi Xue Za Zhi 78:49–51 (Article in Chinese)PubMed Zhang X, Jiang H, Lai J (1998) Relationship between the risk factors of coronary artery disease and the severity of coronary artery lesions. Zhonghua Yi Xue Za Zhi 78:49–51 (Article in Chinese)PubMed
19.
Zurück zum Zitat Birgelen C von, Hartmann M, Mintz GS et al (2004) Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation 110:1579–1585CrossRef Birgelen C von, Hartmann M, Mintz GS et al (2004) Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation 110:1579–1585CrossRef
20.
Zurück zum Zitat Kim SW, Mintz GS, Escolar E et al (2006) The impact of cardiovascular risk factors on subclinical left main coronary artery disease: an intravascular ultrasound study. Am Heart J 152:693.e7–693.e12PubMedCrossRef Kim SW, Mintz GS, Escolar E et al (2006) The impact of cardiovascular risk factors on subclinical left main coronary artery disease: an intravascular ultrasound study. Am Heart J 152:693.e7–693.e12PubMedCrossRef
21.
Zurück zum Zitat Versteylen MO, Joosen IA, Shaw LJ et al (2011) Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events. J Nucl Cardiol 18:904–911PubMedCentralPubMedCrossRef Versteylen MO, Joosen IA, Shaw LJ et al (2011) Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events. J Nucl Cardiol 18:904–911PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Chung CP, Oeser A, Avalos I et al (2006) Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 8:R186PubMedCentralPubMedCrossRef Chung CP, Oeser A, Avalos I et al (2006) Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 8:R186PubMedCentralPubMedCrossRef
Metadaten
Titel
Framingham risk score and severity of coronary artery disease
verfasst von
M.R. Sayin, MD
M.A. Cetiner
T. Karabag
I. Akpinar
E. Sayin
M.A. Kurcer
S.M. Dogan
M. Aydin
Publikationsdatum
01.08.2014
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe 5/2014
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-013-3881-4

Weitere Artikel der Ausgabe 5/2014

Herz 5/2014 Zur Ausgabe

CME Zertifizierte Fortbildung

Kardiale Probleme in der Schwangerschaft

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.